Capital Fund Management (CFM)’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-8,300
| Closed | -$1.47M | – | 1742 |
|
|
2020
Q1 | $1.47M | Sell |
8,300
-136,200
| -94% | -$25.6M | 0.02% | 625 |
|
|
2019
Q4 | $27.6M | Sell |
144,500
-26,800
| -16% | -$4.83M | 0.22% | 109 |
|
|
2019
Q3 | $28.8M | Sell |
171,300
-151,900
| -47% | -$24.7M | 0.26% | 97 |
|
|
2019
Q2 | $54.1M | Buy |
323,200
+8,500
| +3% | +$1.18M | 0.49% | 21 |
|
|
2019
Q1 | $46.1M | Sell |
314,700
-59,600
| -16% | -$8.64M | 0.41% | 36 |
|
|
2018
Q4 | $50M | Sell |
374,300
-124,200
| -25% | -$20.4M | 0.44% | 33 |
|
|
2018
Q3 | $95M | Buy |
498,500
+8,100
| +2% | +$1.49M | 0.52% | 19 |
|
|
2018
Q2 | $81.8M | Sell |
490,400
-198,100
| -29% | -$31.8M | 0.43% | 26 |
|
|
2018
Q1 | $116M | Sell |
688,500
-88,900
| -11% | -$14.9M | 0.7% | 2 |
|
|
2017
Q4 | $127M | Buy |
777,400
+576,700
| +287% | +$103M | 0.7% | 12 |
|
|
2017
Q3 | $41.1M | Buy |
200,700
+149,800
| +294% | +$34.8M | 0.3% | 91 |
|
|
2017
Q2 | $12.4M | Sell |
50,900
-92,500
| -65% | -$21.7M | 0.1% | 260 |
|
|
2017
Q1 | $34.3M | Sell |
143,400
-83,600
| -37% | -$19.5M | 0.29% | 94 |
|
|
2016
Q4 | $47.7M | Buy |
227,000
+218,900
| +2,702% | +$45.3M | 0.41% | 47 |
|
|
2016
Q3 | $1.87M | Buy |
8,100
+4,400
| +119% | +$1.08M | 0.02% | 782 |
|
|
2016
Q2 | $855K | Buy |
+3,700
| New | +$853K | 0.01% | 1003 |
|
|
2016
Q1 | – | Sell |
-2,800
| Closed | -$875K | – | 1984 |
|
|
2015
Q4 | $875K | Sell |
2,800
-3,400
| -55% | -$1.01M | 0.01% | 918 |
|
|
2015
Q3 | $1.69M | Buy |
+6,200
| New | +$1.9M | 0.02% | 667 |
|
|
2015
Q1 | – | Sell |
-6,800
| Closed | -$1.75M | – | 1847 |
|
|
2014
Q4 | $1.75M | Sell |
6,800
-20,400
| -75% | -$5.1M | 0.02% | 720 |
|
|
2014
Q3 | $6.56M | Sell |
27,200
-22,800
| -46% | -$5.1M | 0.07% | 341 |
|
|
2014
Q2 | $11.2M | Buy |
50,000
+26,900
| +116% | +$5.57M | 0.12% | 209 |
|
|
2014
Q1 | $4.75M | Sell |
23,100
-1,700
| -7% | -$337K | 0.06% | 386 |
|
|
2013
Q4 | $4.17M | Buy |
24,800
+10,200
| +70% | +$1.59M | 0.05% | 442 |
|
|
2013
Q3 | $2.1M | Sell |
14,600
-12,600
| -46% | -$1.68M | 0.03% | 622 |
|
|
2013
Q2 | $3.43M | Buy |
+27,200
| New | +$3.08M | 0.05% | 460 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Capital Fund Management (CFM)'s AGN Position: Q2 2020 in Review
Capital Fund Management (CFM) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 21,914 shares — an estimated $3.88M sold.
Capital Fund Management (CFM) first reported a position in AGN in Q3 2014 and held it in 11 quarters. The position peaked at $61.3M in Q4 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Capital Fund Management (CFM) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Capital Fund Management (CFM) sold 21,914 Allergan plc shares in Q2 2020, an estimated $3.88M.
- Capital Fund Management (CFM) first reported a position in Allergan plc in Q3 2014 and held it in 11 quarters.
- Capital Fund Management (CFM)'s Allergan plc position peaked at $61.3M in Q4 2017.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Capital Fund Management (CFM)'s 13F filing for Q2 2020, filed 13 Aug 2020.